Ionis Pharmaceuticals IONS Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's change in other assets?
- Ionis Pharmaceuticals (IONS) reported change in other assets of $7.39M in Q1 2026.
- How has Ionis Pharmaceuticals's change in other assets changed year-over-year?
- Ionis Pharmaceuticals's change in other assets decreased by 40.2% year-over-year, from $12.37M to $7.39M.
- What is the long-term trend for Ionis Pharmaceuticals's change in other assets?
- Over 2 years (2021 to 2024), Ionis Pharmaceuticals's change in other assets has grown at a 455.7% compound annual growth rate (CAGR), from $877K to $27.08M.
- What does change in other assets mean?
- The net change in miscellaneous short-term assets held by the company.
- How do you interpret change in other assets?
- A large negative change indicates cash is being tied up in non-operating assets, while a positive change releases cash.
- How does change in other assets compare across companies?
- Standard line item; peers often group various small asset changes here, making it a catch-all for working capital adjustments.